3,4-dihydroxyphenylacetic acid has been researched along with jl 13 compound in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Garavaglia, C; Invernizzi, R; Samanin, R | 1 |
1 other study(ies) available for 3,4-dihydroxyphenylacetic acid and jl 13 compound
| Article | Year |
|---|---|
JL13, a pyridobenzoxazepine compound with potential atypical antipsychotic activity, increases extracellular dopamine in the prefrontal cortex, but not in the striatum and the nucleus accumbens of rats.
Topics: 3,4-Dihydroxyphenylacetic Acid; Analysis of Variance; Animals; Antipsychotic Agents; Brain; Cardiotonic Agents; Chromatography, High Pressure Liquid; Clozapine; Dopamine; Dose-Response Relationship, Drug; Homovanillic Acid; Injections, Intraperitoneal; Male; Microdialysis; Rats | 2000 |